Viewing Study NCT01851369

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-02-26 @ 11:05 AM
Study NCT ID: NCT01851369
Status: COMPLETED
Last Update Posted: 2024-05-08
First Post: 2013-05-08
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphomas View
None Solid Tumors View
None NSCLC View
None Metastatic Colon Carcinoma View
None Granulosa Cell Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumors View
None Lymphomas View
None DNA Damage View
None Pharmacodynamics View
None Pharmacokinetics View